Two mechanisms may be involved in OPN’s detrimental effects: by stimulating the pro-inflammatory mediators in MS lesions, and by inhibiting the apoptosis of autoreactive immune cells (Carecchio and Comi, 2011). Here, SPP1 is linked to myeloid sarcoma.